Passkey Therapeutics
Biotechnology Research
One Kendall Square, Building 200
17 employees
- Employees
- 17
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Passkey Therapeutics Overview
- Headquarters
- One Kendall Square, Building 200
- Website
- passkeytx.com
- Industry
- Biotechnology Research
- Employees
- 17
- Funding
- 20.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Passkey Therapeutics
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.
Passkey Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Passkey Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| William Chen | Co-founder - Venture - Biotech - Therapeutics - Data Science | Boston, Massachusetts, United States |
Email
|
| Marie Hanabusa | Business Operations Lead - Project/program Manager - International Collaborator - Organizer - Martial Artist | Greater Boston, United States |
Email
Phone
|
| Bruce Beutel | Biotech Entrepreneur |
View
|
|
| Huy Tu | Experienced Life-science Professional - Immunology - Vaccines - Cell Therapies | Cambridge, Massachusetts, United States |
Email
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Manager
1 profile
Compare Similar Companies to Passkey Therapeutics
Enveda
Biotechnology Research
Dyno Therapeutics
Biotechnology Research
Dewpoint Therapeutics
Biotechnology Research
Be Biopharma
Biotechnology
AvenCell
Biotechnology
Seaport Therapeutics
Biotechnology Research
Triveni Bio
Biotechnology Research
Atavistik Bio
Biotechnology Research
Judo Bio
Biotechnology Research
Breakout Ventures
Venture Capital And Private Equity Principals